To include your compound in the COVID-19 Resource Center, submit it here.

Pillars of strength

The Column Group looks to make bigger, but fewer, bets with its new fund

The Column Group plans to invest its biggest fund yet in fewer companies. The goal is to infuse enough capital into platform-based newcos that they can turn a blind eye to the capital markets.

At

Read the full 350 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE